Pfizer (37) | Human Resources (11)

Browse by Subcategory

Recent Contracts

Amendment No. 4 to the Separation and Distribution Agreement, dated as of November 15, 2020, by and between us and Upjohn Inc. (Pursuant to Item 601(b)(2) of Regulation S-K, the... (Filed With SEC on February 25, 2021)
Amended and Restated Pfizer Inc. Global Performance Plan (Filed With SEC on February 25, 2021)
Amendment No. 3 to Amended and Restated Deferred Compensation Plan (Filed With SEC on February 25, 2021)
Amendment No. 3 to the Pfizer Inc. Executive Severance Plan (Filed With SEC on February 25, 2021)
Consulting Agreement between Ian C. Read and Pfizer Inc., dated December 13, 2019 (Filed With SEC on December 19, 2019)
Amendment No. 2 to Wyeth 2005 (409A) Deferred Compensation Plan (Filed With SEC on February 25, 2021)
Amendment No. 3, dated as of September 18, 2020, to the Separation and Distribution Agreement, dated as of July 29, 2019, by and between Pfizer Inc. and Upjohn Inc. (Pursuant to... (Filed With SEC on November 5, 2020)
Amendment No. 2, dated as of May 29, 2020, to the Separation and Distribution Agreement, dated as of July 29, 2019, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on June 1, 2020)
Amendment No. 1 to the Separation and Distribution Agreement, dated as of February 18, 2020, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on February 27, 2020)
Amendment No. 2 to the Pfizer Inc. Executive Severance Plan (Filed With SEC on February 27, 2020)
Separation and Distribution Agreement, dated as of July 29, 2019, by and among Pfizer Inc. and Upjohn Inc (Filed With SEC on July 29, 2019)